Monash IVF Group Limited (ASX:MVF)
0.7900
+0.0200 (2.60%)
Sep 17, 2026, 4:10 PM AEST
Monash IVF Group Market Cap
Monash IVF Group has a market cap or net worth of 307.81 million as of September 17, 2026. Its market cap has increased by 17.04% in one year.
Market Cap
307.81M
Enterprise Value
502.90M
Revenue
269.46M
Ranking
n/a
PE Ratio
41.58
Stock Price
0.79
ChartMarket Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 307.81M, a decrease of -42.41%. That is a compound annual growth rate of -4.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 307.81M | 7.48% |
| Dec 31, 2025 | 286.38M | -42.13% |
| Dec 31, 2024 | 494.84M | -2.31% |
| Dec 29, 2023 | 506.53M | 36.13% |
| Dec 30, 2022 | 372.10M | -9.48% |
| Dec 31, 2021 | 411.06M | 34.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.41B |
| Integral Diagnostics | 856.72M |
| Australian Clinical Labs | 505.18M |
| Healius | 308.62M |
| Cryosite | 57.60M |
| Microba Life Sciences | 38.72M |
| Rhythm Biosciences | 29.02M |
| BCAL Diagnostics | 26.18M |